专利号:US-7598291-B2 优先权日:2004-09-02 标题 :Methods and compositions for enhancing collagen and proteoglycan synthesis in the skin 发明人:NIMNI MARCEL; HAN BO 权利人:NIMNI MARCEL; HAN BO 摘要:A composition for application to the skin can stimulate the in vivo synthesis of collagen and proteoglycans and improve the appearance of the skin, increasing its elasticity and fullness. In general, a composition according to the present invention comprises: (1) an antioxidant compound in a quantity sufficient to enhance collagen synthesis in the skin; (2) an organic penetrant in which the antioxidant compound is soluble in a sufficient quantity that a concentration of the antioxidant compound sufficient to enhance collagen synthesis can be applied topically and penetrate the skin; (3) a mixture of essential amino acids; (4) a supplemental source of sulfur; and (5) a topical pharmaceutically acceptable carrier. The antioxidant compound can be lipoic acid, a lipoic acid analogue or derivative, a bioflavonoid, a constituent of ginkgo, or an isoflavone. The organic penetrant is preferably benzyl alcohol. Other ingredients, such as esters of tocopherol and ascorbic acid, can be included.
专利号:US-2010160244-A1 优先权日:2004-09-02 标 题 :Methods and compositions for enhancing collagen, proteoglycan, and glutathione synthesis in the skin 发明人:NIMNI MARCEL; HAN BO 权利人:NIMNI MARCEL; HAN BO 摘要:A composition for application to the skin can stimulate the in vivo synthesis of collagen and proteoglycans and improve the appearance of the skin, increasing its elasticity and fullness. In general, a composition according to the present invention comprises: (1) an antioxidant compound in a quantity sufficient to enhance collagen synthesis in the skin; (2) an organic penetrant in which the antioxidant compound is soluble in a sufficient quantity that a concentration of the antioxidant compound sufficient to enhance collagen synthesis can be applied topically and penetrate the skin; (3) a mixture of essential amino acids or hydrolyzed whey protein; (4) a supplemental source of sulfur; and (5) a topical pharmaceutically acceptable carrier. The antioxidant compound can be lipoic acid or a lipoic acid analogue or derivative. The organic penetrant is preferably benzyl alcohol. Other ingredients, such as esters of tocopherol and ascorbic acid, can be included.
专利号:US-6693091-B2 优先权日:2002-03-29 标 题 :Analogs of terpene trilactones from Ginkgo biloba for bioorganic and imaging studies 发明人:STROMGAARD KRISTIAN; SUEHIRO MAKIKO; NAKANISHI KOJI 权利人:UNIV COLUMBIA 摘要:A compound having the structure: n wherein R 1 is H, OH, a photoactivatable moiety, a fluorescent moiety, or a radioactive moiety; n wherein R 2 is H, OH, a photoactivatable moiety, a fluorescent moiety, or a radioactive moiety; n wherein R 3 is H or OH; n wherein R 4 is H, OH, a photoactivatable moiety, a fluorescent moiety, or a radioactive moiety; and n wherein at least one of R 1 , R 2 , R 3 , or R 4 is a photoactivatable moiety, a fluorescent moiety, or a radioactive moiety. Optically pure enantiomers and salts of the compound are also described. Also, the synthesis of the compound, and uses of the compound, such as in a method for detecting the localization of, or identifying, receptors, enzymes or other targets, whether in a cell or in a subject.
专利号:US-2009221019-A1 优先权日:2005-06-22 标 题:Core-Modified Terpene Trilactones From Ginkgo Biloba Extract and Biological Evaluation Thereof 发明人:NAKANISHI KOJI; DZYUBA SERGEI; ISHII HIDEKI 权利人:NAKANISHI KOJI; DZYUBA SERGEI; ISHII HIDEKI 摘要:Lactone-rings of ginkgolides are converted into the corresponding tetrahydrofuran moieties via DIBAL-H reduction followed by deoxygenation of the formed lactols with Et 3 SiH/BF 3 Et 2 O producing a series of lactol-free ginkgolides. The present invention also relates to synthesis of hydroxyl-free, or hydroxyl-free and lactone-free, ginkgolides and bilobalides.
专利号:US-12102085-B2 优先权日:2013-10-18 标题 :Insecticidal active mixtures comprising carboxamide compound 发明人:SIKULJAK TATJANA; GEWEHR MARKUS 权利人:BASF AGROCHEMICAL PRODUCTS BV 摘要:The present invention relates to pesticidal mixtures comprising as active compound I an insecticidal active carboxamide derivative and at least one active compound II selected from a group M comprising acteylcholine esterase inhibitors, GABA-gated chloride channel antagonists, sodium channel modulators, nicotinic acteylcholine receptor agonists/antagonists, allosteric nicotinic acetylcholine receptor activators, chloride channel activators, juvenile hormone mimics, homopteran feeding blockers, mit grow inhibitors, inhibitors of mitochondrial ATP synthase, uncouplers of the oxidative phosphorylation, inhibitors of the chitin biosynthesis, moulting disruptors, ecdyson receptor agonists, octamin receptor agonists, inhibitors of the MET, voltage-dependent sodium channel blockers, inhibitors of the lipid synthesis, ryanodine receptor modulators and other compounds as defined in the description, in synergistically effective amounts.The invention relates further to methods and use of these mixtures for combating and controlling insects, arachnids or nematodes in and on plants, and for protecting such plants being infested with pests, especially also for protecting plant proparagation material, such as seeds.
专利号:CN-108117561-A 优先权日:2016-11-30 标 题 :A kind of mesylate amine ginkgolide B metabolite and its synthesis and purification method
1: Ma S, Liu X, Xu Q, Zhang X. Transport of ginkgolides with different lipophilicities based on an hCMEC/D3 cell monolayer as a blood-brain barrier cell model. Life Sci. 2014 Oct 2;114(2):93-101. doi: 10.1016/j.lfs.2014.08.006. Epub 2014 Aug 17. doi: 10.1002/bmc.3515. Epub 2015 Jul 23. doi: 10.1016/j.intimp.2015.02.001. Epub 2015 Feb 11. doi: 10.1016/j.jpba.2014.07.030. Epub 2014 Aug 2. doi: 10.4062/biomolther.2015.077. Epub 2016 Jan 1. 6: Wang X, Jiang CM, Wan HY, Wu JL, Quan WQ, Wu KY, Li D. Neuroprotection against permanent focal cerebral ischemia by ginkgolides A and B is associated with obstruction of the mitochondrial apoptotic pathway via inhibition of c-Jun N-terminal kinase in rats. J Neurosci Res. 2014 Feb;92(2):232-42. doi: 10.1002/jnr.23306. Epub 2013 Nov 4. doi: 10.1055/s-0032-1314965. Epub 2012 Jun 14. doi: 10.1124/dmd.112.045013. Epub 2012 Mar 5. doi: 10.1016/j.jpba.2015.10.029. Epub 2015 Oct 26. doi: 10.1016/j.jpba.2016.04.035. Epub 2016 Apr 25. Chinese. doi: 10.1074/jbc.M109.079319. Epub 2010 Jan 27. 13: Si HH, Geng T, Sun XP, Zhao J, Xue J. [Absolute bioavailability of ginkgolide compounds in rats]. Zhongguo Zhong Yao Za Zhi. 2015 Jul;40(14):2882-6. Chinese. doi: 10.1016/j.jss.2011.03.018. Epub 2011 Apr 1.
合成参考文献
参考文献:10.1016/s0024-3205(01)01557-0 摘要:Sasaki K, Hatta S, Wada K, Ueda N, Yoshimura T, Endo T, Sakata M, Tanaka T, Haga M. Effects of extract of Ginkgo biloba leaves and its constituents on carcinogen-metabolizing enzyme activities and glutathione levels in mouse liver. Life Sci. 2002 Feb 22;70(14):1657–67. doi: 10.1016/s0024-3205(01)01557-0. 参考文献:10.1021/jf011682s 摘要:Bedir E, Tatli II, Khan RA, Zhao J, Takamatsu S, Walker LA, Goldman P, Khan IA. Biologically active secondary metabolites from Ginkgo biloba. J Agric Food Chem. 2002 May 22;50(11):3150–5. doi: 10.1021/jf011682s.